More SEC Filings
View Older Stories View Newer Stories-
Form 8-K PIMCO Asset-Based Lendin For: Jan 28
-
Form 424B2 BofA Finance LLC
-
Form D/A VS ASSET FUND LP
-
Form 497K MASSMUTUAL PREMIER FUNDS
-
Form 4 HEALTHPEAK PROPERTIES, For: Jan 28 Filed by: Johnston Shawn G
-
Form 4 Day One Biopharmaceutica For: Jan 30 Filed by: Bender Jeremy
-
Form PREM14A JANUS HENDERSON GROUP For: Jan 30
-
Form D/A VERIQUANT FUND LP
-
Form 4 Artisan Partners Asset For: Jan 29 Filed by: JOERRES JEFFREY A
-
Form 497K MASSMUTUAL SELECT FUNDS
-
Form 497K MASSMUTUAL SELECT FUNDS
-
Form 497K MASSMUTUAL PREMIER FUNDS
-
Form 424B2 UBS AG
-
Form S-3/A Grayscale Zcash Trust
-
Form 6-K AMDOCS LTD For: Jan 30
-
Form 4 Day One Biopharmaceutica For: Jan 30 Filed by: Merendino Lauren
-
Form 5 FIRST KEYSTONE CORP For: Dec 31 Filed by: Jezewski Michael L
-
Form 424B2 ROYAL BANK OF CANADA
-
Form D/A BP LNK LLC
-
Form 6-K BRASKEM SA For: Mar 31
-
Form 8-K Ondas Inc. For: Jan 28
-
Form 424B3 BARNWELL INDUSTRIES INC
-
Form 497K MASSMUTUAL PREMIER FUNDS
-
Form 497K MASSMUTUAL PREMIER FUNDS
-
Form 8-K Aspira Women's Health For: Jan 30
-
Form 424B2 CITIGROUP INC
-
Form 4 Day One Biopharmaceutica For: Jan 30 Filed by: Dubow Adam
-
Form F-6 POS Auto Trader Group plc/AD Filed by: Deutsche Bank Trust Co Americas/ ADR Group
-
Form S-4 BLACK HILLS CORP /SD/
-
Form 424B3 CXApp Inc.
-
Form D/A KKR Asia Tactical Credit
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 497K MASSMUTUAL SELECT FUNDS
-
Form 8-K HEALTHY CHOICE WELLNESS For: Dec 31
-
Form S-1/A Hillhouse Frontier Holdi
-
Form 8-K CXApp Inc. For: Jan 26
-
Form 6-K OKYO Pharma Ltd For: Jan 30
-
Form 497K MASSMUTUAL PREMIER FUNDS
-
Form 424B2 UBS AG
-
Form DEF 14A HARVARD BIOSCIENCE INC For: Mar 06
-
Form 497K CONESTOGA FUNDS
-
Form 15-12G Fusion Fuel Green PLC
-
Form 8-A12B Jaguar Uranium Corp.
-
Form 6-K Nyxoah SA For: Jan 30
-
Form 6-K Ero Copper Corp. For: Jan 30
-
Form S-8 Yellowstone Midco Holdin
-
Form D Stratton Industrial Part
-
Form 424B2 UBS AG
-
Form D Affiniti Ventures, Inc.
-
Form 497K LOOMIS SAYLES FUNDS II

